Led · Equity · May 2022

Healthmap Solutions is an NCQA-accredited kidney population health management company based in Tampa, FL, led by CEO Eric Reimer. The company uses advanced predictive analytics and clinical expertise to provide early kidney disease identification and recommend clinically proven interventions to delay or slow disease progression. Healthmap Care Navigation teams work with patients and a full spectrum of providers to maintain access, minimize disruption, and deliver personalized whole-person care. It serves health plans, health systems, accountable care organizations, and provider groups under risk-based arrangements. The company is contracted to serve over 160,000 individuals living with kidney disease and manages over $3 billion in healthcare spend through those arrangements. Healthmap says it will use the new funding to support ongoing expansion of its business. Healthmap Solutions provides an end-to-end kidney health management solution using advanced technology, predictive analytics, and clinical expertise to detect kidney disease early and recommend interventions to delay progression. Its Care Navigation team works with patients and a full spectrum of providers—including primary care, nephrology, cardiology, endocrinology, and dialysis—to deliver personalized, whole-person care. The company emphasizes proactive care transitions and optimization of renal replacement therapy, with a focus on in-home dialysis and transplant. Healthmap also uses proprietary AI to build individualized care plans at scale. The company has experienced rapid operational growth, expanding from 60 employees in summer 2020 to over 500 by the end of 2022 and expects to have more than ~150,000 members under contract across Commercial, Medicare and Medicaid lines by year-end. Healthmap plans to use new funding to fuel that growth and continue R&D initiatives to improve chronic kidney disease care.

Participated · Series D · May 2021

Vida Health delivers a full‑stack virtual chronic care platform that combines an AI‑personalized experience with human clinicians (therapists, coaches, dietitians, diabetes educators) via video, messaging, and digital content. The company treats mental and physical conditions together, applying cognitive behavioral science and machine learning to drive long‑term behavior change. Vida expanded a nationwide provider network by more than 400% and launched a complete Spanish experience while tripling revenue since the start of 2020. Its customers include large employers (Boeing, Visa, Cisco, eBay) and major health plans (Centene, Humana, Blue Cross Blue Shield plans). Vida reports more than 400,000 people with diabetes have access to its services and saw a 6000% increase in therapy sessions year over year. The company plans to scale its clinician network, deepen machine learning capabilities, broaden commercial efforts, and expand mental health and chronic‑disease offerings. Vida commercially launched a direct-to-consumer iPhone app offering app-based health and wellness coaching. The service connects users to nutritionists, physicians, diabetes educators, nurses and coaches across eight initial programs including weight loss, fitness, detox, stress reduction, cholesterol lowering, blood pressure lowering and diabetes prevention. Programs are priced at $15 per week and Vida says its coaches have experience with more than 20 health conditions. The company has begun three-month IRB clinical trials at MD Anderson Cancer Center and will soon begin one at Duke University Hospital; it is also working with Duke on a cardiac rehab program and has integrated MD Anderson recovery protocols for certain cancers. Vida plans to develop an Android app and is testing other distribution channels, including employer per-employee pricing and offerings to providers; insurance companies are on the roadmap. The company is led by CEO and founder Stephanie Tilenius, who previously worked at Kleiner Perkins, Google and eBay/PayPal.

Participated · Series D · May 2021

Vida Health offers a clinically validated virtual cardiometabolic care platform that combines prescriptive and behavioral therapies through an AI-powered personalized mobile app and a national network of providers. Its programs include video sessions, asynchronous messaging, and digital content to prevent and manage diabetes, obesity, hypertension, and related mental health conditions. Vida emphasizes a body-and-mind approach and says it was an early innovator—integrating Cognitive Behavioral Therapy into cardiometabolic care, launching a full Spanish intervention, and combining behavior change with GLP-1 prescribing. Some of America’s largest employers and health plans are customers, and the company markets its model on delivering clinical and financial outcomes for whole populations. Vida frames its mission as increasing access to innovative, lower-cost treatments to improve patient outcomes and address growing unmet needs in cardiometabolic disease, which affects roughly 40% of U.S. adults. The company intends to further scale and pursue growth opportunities in the rapidly expanding GLP-1 market, where demand is projected to reach $100 billion by 2030. Vida Health operates a virtual chronic care platform that combines an AI-powered, personalized app with video sessions, messaging, and a network of licensed clinicians, coaches, dietitians, and diabetes educators. The company focuses on integrated mental and physical care, with heavily used programs for Type 2 diabetes and mental health. Vida has more than tripled its revenue since the beginning of 2020 and expanded its clinician network by over 400%; more than 400,000 people with diabetes currently have access to Vida’s services. The company launched a complete, full-stack Spanish experience and reports a 6000% increase in therapy sessions last year, with multiple JMIR studies showing A1C reductions and improvements in depression/anxiety outcomes. Vida plans to use new funding to grow its clinician and coaching network, deepen machine-learning capabilities, broaden commercial efforts, and scale its nationwide mental health coaching program. Clients include employers such as Boeing, Visa, Cisco, and eBay, and large health plans including Centene, Humana, and Blue Cross Blue Shield plans. Vida Health is a virtual care platform built to treat multiple chronic health conditions simultaneously using machine learning alongside human health coaches and therapists. Launched in 2014 and led by CEO Stephanie Tilenius, the company delivers services via a mobile platform that supports prevention, management and reversal of conditions such as pre‑diabetes, diabetes, hypertension, obesity, depression and anxiety. The platform integrates deep individual expert care with data‑driven technology and remote monitoring. Vida sells its services to employers and health plans to deliver improved health outcomes and cost savings. In January 2020 the company raised $25M in funding led by Ally Bridge Group with participation from returning investors including AME Cloud Ventures, Aspect Ventures, Canvas Ventures, NGP Capital, Webb Investment Network and Workday Ventures. Vida says it will use the funds to expand operations and broaden its business reach. Vida Health is a personalized virtual care platform that combines digital therapeutic programs with health coaching and therapy delivered via mobile and online channels. The platform supports individuals in managing and reversing chronic physical and behavioral health conditions such as pre-diabetes, diabetes, hypertension, obesity, depression and anxiety. The company is led by founder and CEO Stephanie Tilenius and is based in San Francisco. Vida is deployed by Fortune 1000 employers and healthcare organizations, with customers including Avalon Bay, eBay, PayPal, Steelcase, FICO, Cisco, Visa, Veterans Affairs, MD Anderson Cancer Center, Aurora Health Care and Partners Healthcare. In June 2019 the company closed a $30M Series C and said it will use the funds to expand sales and marketing and to grow its national coaching and therapy network. Investors in the round included GuideWell Mutual Holding Corporation, Teladoc Health, Workday Ventures and existing backers Canvas, Aspect Ventures and NGP Capital. Vida Health offers a HIPAA-compliant, subscription-based app that pairs patients with a network of thousands of health coaches, from nutritionists to therapists. Its platform addresses more than 25 chronic conditions and integrates data from users' doctors, insurers, and up to 100 apps and devices (including MyFitnessPal, Garmin, Fitbit, Strava, and Apple Watch). Vida serves both direct-to-consumer users and enterprise customers, with clients that include Stanford, Duke University, MD Anderson Cancer Center, United Healthcare, and eBay. The company says “tens of thousands” of people have received coaching on the platform and that it has collected more than 7 million data points. Vida is paid by both employers and insurance companies, though the CEO declined to specify whether D2C or enterprise revenue is larger. The company aims to use its accumulated data to improve and expand its product effectiveness over time.

Participated · Series B · May 2019

Cardinal Analytx Solutions is a Palo Alto-based, AI-enabled health insights company spun out of StartX in 2017. Founded by Stanford professors Drs. Arnie Milstein and Nigam Shah and led by CEO Linda T. Hand, the company combines AI-enabled data science with health insights to identify people at high risk of rising cost and worsening health. It can predict specific types of high-cost, high-acuity events well in advance and match members with interventions and higher-value providers. Cardinal partners with health plans, employers and providers across the nation and has completed multiple pilots. Earlier this year it announced its first multiyear customer, Premera Blue Cross. The company plans to use the new funding to extend its lead in machine learning through investments in talent and technology. Cardinal Analytx Solutions builds advanced machine learning and AI-driven predictive analytics to identify impending healthcare costs and flag potential high-expense health plan enrollees. The company's platform provides targeted clinical recommendations designed to improve patient outcomes and contain costs. Cardinal Analytx was spun out of the Stanford-affiliated StartX accelerator and is led by CEO Thomas McKinley. It was co-founded by Stanford professors Arnie Milstein and Nigam Shah, who bring managed care and biomedical data science expertise. The company is based in Palo Alto, California. Cardinal Analytx recently completed a Series A financing to support product and team expansion.